{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:26:38Z","timestamp":1787030798289,"version":"build-2736575974"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pollen\u2013food allergy syndrome (PFAS) usually causes localized oral symptoms through cross-reactivity between pollen allergens and plant-derived foods. However, the soybean PR-10 allergen Gly m 4 can provoke systemic reactions, including anaphylaxis. Proton pump inhibitors (PPIs) are recognized in PFAS consensus statements as potential cofactors, although acid suppression is not established as a major cofactor for food-induced anaphylaxis overall. Increasingly prescribed potassium-competitive acid blockers (P-CABs), including vonoprazan, provide potent and sustained acid suppression beyond conventional PPIs. To our knowledge, severe PR-10\u2013related PFAS temporally associated with P-CAB therapy has not been previously reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 59-year-old woman had experienced mild oral allergy syndrome\u2013like symptoms, including lip swelling, after soy milk ingestion, while tolerating other soybean products. Two weeks after starting vonoprazan 20\u2005mg for gastroesophageal reflux disease, she developed generalized urticaria, throat discomfort, and dyspnea after dinner containing inadequately cooked soybean sprouts, requiring epinephrine. Three months later, within 15\u2005min after eating ramen containing inadequately cooked soybean sprouts, she developed generalized urticaria and dyspnea, requiring hospitalization and epinephrine. Component-resolved testing showed positive specific IgE to Gly m 4, whereas crude soybean extract,\n                      <jats:italic>\u03c9<\/jats:italic>\n                      -5 gliadin, and other food-related allergens were negative. These findings supported Gly m 4\u2013mediated PR-10\u2013related PFAS. Because vonoprazan was the only new factor common to both episodes, it was considered a possible cofactor. Vonoprazan was discontinued, and the patient was advised to avoid soy milk and undercooked soybean sprouts and to be cautious regarding recognized cofactors. Over 6 months of follow-up, no further anaphylaxis occurred, and soybean sprouts were tolerated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To our knowledge, this is the first report of severe Gly m 4\u2013mediated PFAS anaphylaxis temporally associated with vonoprazan use. Potent P-CAB\u2013mediated acid suppression may theoretically reduce gastric degradation of labile PR-10 allergens and increase systemic exposure to immunologically active Gly m 4, although causality was not proven because oral food challenge with and without vonoprazan was not performed. These findings suggest that, in PR-10\u2013related PFAS, medication review and anticipatory counseling regarding potent acid suppression, particularly P-CAB therapy, may be important in patients with PFAS, even when previous symptoms have been limited to mild oral reactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/falgy.2026.1893499","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:27:58Z","timestamp":1787027278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: First report of vonoprazan-associated severe Gly m 4\u2013mediated PFAS anaphylaxis in the era of potent acid suppression"],"prefix":"10.3389","volume":"7","author":[{"given":"Makoto","family":"Nojo","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Uno","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae","family":"Kawafune","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reira","family":"Masuda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Ebato","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Uchida","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Sagara","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa Medical University School of Medicine","place":["Shinagawa City, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3950\/jibiinkoka.123.485","article-title":"National epidemiological survey of nasal allergy 2019 in Japan: a brief report (comparison with 1998 and 2008 surveys) \u2014 otolaryngologists and their families as subjects \u2014","volume":"123","author":"Matsubara","year":"2020","journal-title":"Nippon Jibiinkoka Gakkai Kaiho (Jibiinkoka)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3345\/cep.2019.00780","article-title":"Pollen-food allergy syndrome in children","volume":"63","author":"Jeon","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e70104","DOI":"10.1111\/pai.70104","article-title":"Evaluation of the incidence of systemic symptoms in PR-10-related pollen-food allergy syndrome in western Japan","volume":"36","author":"Hamada","year":"2025","journal-title":"Pediatr Allergy Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e13854","DOI":"10.1111\/pai.13854","article-title":"EAACI molecular allergology user's guide 2.0","volume":"34","author":"Dramburg","year":"2023","journal-title":"Pediatr Allergy Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.jaci.2007.01.049","article-title":"Clinical characteristics of soybean allergy in Europe: a double-blind, placebo-controlled food challenge study","volume":"119","author":"Ballmer-Weber","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101062","DOI":"10.1016\/j.waojou.2025.101062","article-title":"Risk factorscofactors for heightened anaphylaxis severity in Japanese adults: a 10-year single-center retrospective cohort study","volume":"18","author":"Nojo","year":"2025","journal-title":"World Allergy Organ J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1016\/j.jaip.2024.09.037","article-title":"An international Delphi consensus on the management of pollen-food allergy syndrome: a work group report of the AAAAI adverse reactions to foods committee","volume":"12","author":"Al-Shaikhly","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15386","DOI":"10.3390\/ijms232315386","article-title":"Structural and immunologic properties of the major soybean allergen gly m 4 causing anaphylaxis","volume":"23","author":"Finkina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases","volume":"24","author":"Oshima","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"B10","first-page":"470","article-title":"IgE-mediated allergy from vegetable allergens","volume":"71","author":"Ortolani","year":"1993","journal-title":"Ann Allergy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaci.2003.09.030","article-title":"Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens","volume":"113","author":"Mittag","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B12","year":""}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1893499\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:27:59Z","timestamp":1787027279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1893499\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":12,"alternative-id":["10.3389\/falgy.2026.1893499"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1893499","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1893499"}}